BRCA1 and neoplasm: Furthermore, of the two treatment-naïve patients with somatic BRCA1 variants identified in FFPE tumor samples, we could detect in ctDNA a BRCA1 frameshift somatic variant that was present in the tumor sample with a VAF of 53%, but not the one that had a VAF of only 5.4%.